0023-6499 NDC - UBROGEPANT

Drug Information

Product NDC: 0023-6499

Proprietary Name:

Non Proprietary Name: ubrogepant

Active Ingredient(s):
  • 50 mg/1 UBROGEPANT

Administration Route(s):

Dosage Form(s): TABLET

Labeler Information

Labeler Name: Allergan, Inc.
FDA Application Number:
Start Marketing Date:12/23/2019

Package Information

No. Package Code Package Description Billing Unit
10023-6499-001 BAG in 1 DRUM (0023-6499-00) / 13200 TABLET in 1 BAG

NDC Record

Field Name Field Value Definition
PRODUCT NDC0023-6499The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEDRUG FOR FURTHER PROCESSINGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
NON PROPRIETARY NAMEubrogepantThe non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMETABLETThe translation of the dosage form Code submitted by the firm.
START MARKETING DATE12/23/2019This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEDRUG FOR FURTHER PROCESSINGProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMEAllergan, Inc.Name of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMEUBROGEPANTAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 5/3/2024